Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Hyperparathyroidism secondary
ADR ID BADD_A02136
ADR Hierarchy
05      Endocrine disorders
05.04      Parathyroid gland disorders
05.04.01      Hyperparathyroid disorders
05.04.01.004      Hyperparathyroidism secondary
20      Renal and urinary disorders
20.01      Renal disorders (excl nephropathies)
20.01.01      Renal failure complications
20.01.01.006      Hyperparathyroidism secondary
14      Metabolism and nutrition disorders
14.04      Bone, calcium, magnesium and phosphorus metabolism disorders
14.04.01      Calcium metabolism disorders
14.04.01.022      Hyperparathyroidism secondary
Description Not Available
MedDRA Code 10020708
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Hyperparathyroidism secondary | Renal hyperparathyroidism
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00066Alendronic acid0.000066%
BADD_D00335Calcitonin--
BADD_D00347Candesartan cilexetil0.000841%
BADD_D00494Clodronic acid--
BADD_D00723Doxorubicin0.000112%
BADD_D00979Furosemide0.000014%
BADD_D01567Nilotinib--
BADD_D01599Olanzapine0.000421%
BADD_D01831Prednisolone0.000035%
BADD_D02392Zoledronic acid0.002863%
BADD_D02434Cinacalcet0.000860%
BADD_D02539Calcium0.000391%
The 1th Page    1    Total 1 Pages
ADReCS-Target
ADR Term Drug Name Target